Neural Tissue Engineers are examining the development of innovative approaches to repair and regenerate damaged neural tissues, which are critical for the function of the brain, spinal cord, and peripheral nervous system. Injuries and diseases such as spinal cord injuries, strokes, traumatic brain injuries, and neurodegenerative conditions like Alzheimer’s and Parkinson’s result in significant damage to neural tissues, which often do not regenerate naturally. By applying cutting-edge techniques such as stem cell therapy, tissue engineering, and gene editing, neural tissue engineers aim to stimulate the growth of neurons and glial cells to restore lost functions. Their goal is to create neural tissues that can effectively integrate with the body’s nervous system, offering new hope for patients with conditions that were once thought to be irreversible.
Regenerating damaged tissues, neural tissue engineers face challenges such as immune rejection, the prevention of scar tissue formation, and ensuring proper integration of new tissues into the existing nervous system. To overcome these obstacles, these experts are utilizing advanced technologies like 3D bioprinting, bioactive scaffolds, and electrical stimulation to encourage tissue growth and improve the functionality of regenerated neural tissues. With continued research and technological advances, neural tissue engineers are working toward developing therapies that could significantly improve patient outcomes, restoring not only neurological function but also quality of life for individuals suffering from severe neural injuries and diseases.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy